DUBLIN, Nov. 3, 2022
/PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading
global provider of Consumer Self-Care Products, today
announced that its Board of Directors declared a quarterly dividend
of $0.26 per share, payable on
December 20, 2022, to shareholders of
record on December 2, 2022.
About Perrigo
Perrigo Company plc (NYSE: PRGO) is a leading provider of
Consumer Self-Care Products and over-the-counter (OTC)
health and wellness solutions that enhance individual well-being by
empowering consumers to proactively prevent or treat conditions
that can be self-managed. Visit Perrigo online at
www.perrigo.com.
Forward-Looking Statements
Certain statements in this press release, including statements
regarding expected costs and benefits of investments in infant
formula capacity, are "forward-looking statements." These
statements relate to future events or the Certain statements in
this press release are "forward-looking statements." These
statements relate to future events or the Company's future
financial performance and involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
levels of activity, performance or achievements of the Company or
its industry to be materially different from those expressed or
implied by any forward-looking statements. In some cases,
forward-looking statements can be identified by terminology such as
"may," "will," "could," "would," "should," "expect," "forecast,"
"plan," "anticipate," "intend," "believe," "estimate," "predict,"
"potential" or the negative of those terms or other comparable
terminology. The Company has based these forward-looking statements
on its current expectations, assumptions, estimates and
projections. While the Company believes these expectations,
assumptions, estimates and projections are reasonable, such
forward-looking statements involve known and unknown risks and
uncertainties, many of which are beyond the Company's control,
including: the effect of the coronavirus (COVID-19) pandemic and
its variants and associated supply chain impacts on the Company's
business; general economic, credit, and market conditions; the
impact of the war in Ukraine and
any escalation thereof, including the effects of economic and
political sanctions imposed by the United
States, United Kingdom,
European Union, and other countries related thereto; the outbreak
or escalation of conflict in other regions where we do business;
the risk that potential costs or liabilities incurred or retained
in connection with the Company's sale of its Rx business may exceed
the Company's estimates; and resolution of uncertain tax positions,
including the Company's appeal of the draft and final Notices of
Proposed Assessment ("NOPAs") issued by the U.S. Internal Revenue
Service and the impact that an adverse result in any such
proceedings would have on operating results, cash flows, and
liquidity; pending and potential third-party claims and litigation,
including litigation relating to the Company's restatement of
previously-filed financial information and litigation relating to
uncertain tax positions, including the NOPAs. An adverse result
with respect to the Company's appeal of any material outstanding
tax assessments or pending litigation, including securities or drug
pricing matters, could ultimately require the use of corporate
assets to pay such assessments, damages from third-party claims,
and related interest and/or penalties, and any such use of
corporate assets would limit the assets available for other
corporate purposes. These and other important factors, including
those discussed under "Risk Factors" in the Company's Form 10-K for
the year ended December 31, 2021, and
Form 10-Q for the quarter ended July 2,
2022, as well as the Company's subsequent filings with the
United States Securities and Exchange Commission, may cause actual
results, performance or achievements to differ materially from
those expressed or implied by these forward-looking statements. The
forward-looking statements in this press release are made only as
of the date hereof, and unless otherwise required by applicable
securities laws, the Company disclaims any intention or obligation
to update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/perrigo-announces-quarterly-dividend-301667981.html
SOURCE Perrigo Company plc